SPOTLIGHT -
Slideshow
Author(s):
There are a few things that we all agree on, as reflected in a recent consensus statement.
Psychopharmacology Innovations
Not All That Writhes Is Tardive Dyskinesia
Why Clinicians Should Be Excited About Austedo XR
Austedo XR Approved: A New Treatment Option for Tardive Dyskinesia and Huntington Disease
Managing Tardive Dyskinesia: New Data from Phase 3 Study of Ingrezza
The 2024 APA Annual Meeting: Monday, May 6